View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Liver Injury/Regeneration News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 14, 2023
2 min read
Save

Response to treatment for AKI improved 90-day survival in patients waitlisted for LT

Response to treatment for AKI improved 90-day survival in patients waitlisted for LT

BOSTON — Response to treatment for acute kidney injury correlated with improved 90-day survival and shorter lengths of hospital stay among patients with cirrhosis waitlisted for liver transplant, according to data at The Liver Meeting.

SPONSORED CONTENT
November 08, 2023
3 min read
Save

‘Downstream effects’ of alcohol use disorder swell in wake of COVID-19

‘Downstream effects’ of alcohol use disorder swell in wake of COVID-19

VANCOUVER, British Columbia — With alcohol-related disease still on the rise after surging during the COVID-19 pandemic, an expert here discussed treatment options, including liver transplantation, for patients with alcoholic hepatitis.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
September 05, 2023
5 min read
Save

Former Smash Mouth singer’s death underscores need for liver disease awareness

Former Smash Mouth singer’s death underscores need for liver disease awareness

After nearly a decade of health problems, Steve Harwell, former lead singer and frontman for the band Smash Mouth, died Sept. 4 at age 56, which the band’s manager, Robert Hayes, said was caused by acute liver failure.

SPONSORED CONTENT
August 24, 2023
2 min read
Save

FDA approves Veklury as first antiviral COVID-19 treatment for all liver disease stages

FDA approves Veklury as first antiviral COVID-19 treatment for all liver disease stages

The FDA expanded its approval of Gilead Sciences’ antiviral, Veklury, for the treatment of COVID-19 in patients with mild, moderate and severe hepatic impairment, without requiring dose adjustments, according to a manufacturer release.

SPONSORED CONTENT
July 12, 2023
2 min read
Save

Time-restricted eating may be ‘promising management option’ in patients with NAFLD, NASH

Time-restricted eating may be ‘promising management option’ in patients with NAFLD, NASH

Modifying the timing of daily energy intake may improve metabolic health and restore natural circadian rhythms among patients with nonalcoholic fatty liver disease, according to a review published in Gut.

SPONSORED CONTENT
July 06, 2023
2 min read
Save

History of drug allergies poses risk for ‘fatal outcome’ in drug-induced liver injury

History of drug allergies poses risk for ‘fatal outcome’ in drug-induced liver injury

In patients with idiosyncratic drug-induced liver injury, previous history of an allergic reaction related to drugs correlated with worse clinical outcomes, including death, according to data presented at the EASL Congress.

SPONSORED CONTENT
June 22, 2023
2 min read
Save

Risk for alcohol-related hospitalization fourfold higher in offspring of parents with ALD

Risk for alcohol-related hospitalization fourfold higher in offspring of parents with ALD

Children of parents with alcohol-related liver disease had up to a more than fourfold increased risk for alcohol-related hospitalization, despite a low absolute risk for developing alcohol-related liver disease.

SPONSORED CONTENT
June 17, 2023
4 min read
Save

Lead NASH contender falls short for FDA: Could NAFLD name change shift the status quo?

Lead NASH contender falls short for FDA: Could NAFLD name change shift the status quo?

In the race for a first-to-market therapy for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, there have been multiple hopeful contenders; however, none have yet crossed the FDA finish line.

SPONSORED CONTENT
June 13, 2023
2 min read
Save

Healio seeks nominees for Disruptive Innovators Awards in gastroenterology

Healio seeks nominees for Disruptive Innovators Awards in gastroenterology

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

SPONSORED CONTENT
March 23, 2023
3 min read
Save

Steatosis present in most adults with type 1 diabetes and overweight or obesity

Steatosis present in most adults with type 1 diabetes and overweight or obesity

Hepatic steatosis may be present in most adults with type 1 diabetes, especially those with overweight or obesity, according to a study published in Journal of Diabetes and Its Complications.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails